IGF-1 replacement therapy, within physiological ranges, may restore metabolic balance, improving carbohydrate and lipid metabolism while supporting overall metabolic health and nutrient utilization (7)
While Novo Nordisk has stated this was a deliberate strategic decision rather than an oversight, the result is clear
Cell-based therapies may support oligodendrocyte precursor survival, remyelination, and axonal metabolism through trophic factors, EV cargo, and improved perfusion [23, 27,28,29]
What Needs Your Personal Confirmation Before Buying The Ingredient List Isn't Published This is the most significant transparency gap in the brand's public disclosure, and it deserves a straight read